Terminal Sterilization Services

Terminal Sterilization Services

The terminal sterilization services market refers to the industry that provides sterilization services for medical devices, pharmaceuticals, and other healthcare-related products that require high levels of sterility assurance. The factors such as the increasing demand for sterilization services due to the rising number of cosmetic surgeries and medical procedures, and the rising need for aseptic packaging for pharmaceutical products attributes to the market growth of terminal sterilization services. For instance, as per the International Society of Aesthetic Plastic Surgery’s (ISAPS) annual Global Survey on Aesthetic/Cosmetic Procedures, 19.3% overall increase in procedures performed by plastic surgeons in 2021 with more than 12.8 million surgical, and 17.5 million non-surgical, procedures performed worldwide.

The Terminal Sterilization Services Market is expected to grow at a strong CAGR of 11% during the forecast period owing to the increasing prevalence of hospital-acquired infections. For instance, as per the WHO, out of every 100 patients in acute-care hospitals, seven patients in high-income countries and 15 patients in low- and middle-income countries will acquire at least one healthcare-associated infection (HAI) during their hospital stay.

• Based on product, the market is segmented into ethylene oxide, irradiation, moist heat terminal sterilization, and others. Ethylene oxide held dominating share in 2021. The growth of ethylene oxide in the terminal sterilization services market is primarily driven by the increasing demand for EtO sterilization due to its effectiveness in sterilizing complex and heat-sensitive medical devices and equipment.
• Based on the end-use, the market is segmented into hospitals & clinics, pharma & nutraceuticals, medical device manufacturing/packaging, and others. The pharma & nutraceuticals segment is expected to grow with considerable CAGR in the terminal sterilization services market during the forecast period. This is mainly due to the disposable terminal sterilization services being sterile and designed for single use, which reduces the risk of infection or contamination. In addition, the stringent regulations and guidelines for the production and distribution of sterile pharmaceutical and nutraceutical products are also contributing to segmental growth.
• For a better understanding of the market adoption of the terminal sterilization services industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. North America dominated the terminal sterilization services market in 2021. This can be ascribed to the presence of developed healthcare infrastructures and helpful reimbursement policies. Furthermore, the industry is expanding as a result of the high prevalence of hospital-acquired infections and the high costs of these diseases. For instance, according to the Healthcare Surface Institute, Healthcare-associated infections cost the U.S. healthcare system $28-33 billion each year.
• Some of the major players operating in the market include STERIS; 3M; Getinge AB; Fortive; Belimed AG; Sterigenics U.S., LLC; Fedegari Autoclavi SpA; Olympus Corporation; Andersen Sterilizers; and Steelco S.p.A.